Niu, Xiaojia <br/><br/>
Binding of Released Bim to Mcl-1 is a Mechanism of Intrinsic Resistance to ABT-199 which can be Overcome by Combination with Daunorubicin or Cytarabine in AML Cells.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Sep 2016 
 - 4440-51 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-15-3057  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Bcl-2-Like Protein 11--metabolism<br/>Bridged Bicyclo Compounds, Heterocyclic--pharmacology<br/>Cell Line, Tumor<br/>Cytarabine--pharmacology<br/>Daunorubicin--pharmacology<br/>Drug Resistance, Neoplasm<br/>Drug Synergism<br/>Humans<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Myeloid Cell Leukemia Sequence 1 Protein--metabolism<br/>Protein Stability--drug effects<br/>Sulfonamides--pharmacology